ClinicalTrials.gg
RecruitingNCT05945264Updated Oct 19, 2026

Music Intervention for Preterm Birth

An interventional study of Music Intervention (MI) and Sham Control (SC) in Preterm Birth, sponsored by Columbia University. Recruiting at 2 sites in United States. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Columbia University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 19, 2026Now RecruitingPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Premature Birth by Columbia University — 3 open to participants now, 3 under way, none of them phase 3. Premature Birth · Columbia University.

Planned enrollment
7th of 12
142 · median 146
Started
2026
the only one that year
No phase
12 of 15
3 open now
Registered
15th of 15
by date

Among the 15 studies in Premature Birth by Columbia University, this one is the 7th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 15th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

3 of the 15 studies in Premature Birth by Columbia University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 18 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Premature Birth by Columbia University, or all of them as a file.
02

Study summary

This study will test a music intervention (MI) versus a sham control (SC) arm which only includes a verbal intervention, to determine if the effects of the music intervention will reduce the biological impact of chronic stress among pregnant Black women, reduce preterm birth, and improve infant outcomes.

Read the detailed description

Preterm birth occurs at unacceptably high rates in the United States, with Black women disproportionately affected. A long-recognized risk factor for preterm birth in this population is the relentless exposure to intersectional stress related to racial and sexual discrimination, poverty, and neighborhood disadvantage that Black women often experience from an early age. In this interdisciplinary study, the investigators bring together experts in preterm birth, music therapy, and metabolomics to address this health disparity by testing the efficacy of a live, culturally based music intervention to reduce the production of metabolites and metabolic pathways associated with chronic stress and thereby improve birth outcomes.

03

Conditions studied

  • Preterm Birth

Browse trials for

Keywords

  • Chronic stress
  • Preterm birth
  • Black women stress
  • Metabolomics of chronic stress
  • Music and medicine
  • Music intervention
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 40 years
  • Generally healthy pregnant women in the first trimester of pregnancy

Exclusion criteria

Exclusion Criteria:

  • Non-pregnant women
  • Women with a chronic medical condition that could impact pregnancy health or duration
  • Women regularly taking any medications other than prenatal vitamins
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
142 participants (estimated)

Study arms

  • Experimental
    Music Intervention (MI) Group

    Music therapist will meet individually with each participant and provide music therapy content that reflects their culture and mood states.

    Behavioral: Music Intervention (MI)

  • Active comparator
    Sham Control (SC) Group

    Music/Verbal therapist will meet individually with each participant but will provide verbal discourse only (i.e., no music therapy and verbal intervention only).

    Other: Sham Control (SC)

Interventions

  • BehavioralMusic Intervention (MI)

    The intervention will involve listening, playing and/or singing melodies or songs, that are meaningful to the participant, with interpretation/reflection on their relevance/capacity to alter stress.

  • OtherSham Control (SC)

    The intervention will be to support a woman to talk about anything she wants that is important to her.

    Also known as: Verbal intervention

06

What researchers measure

Primary outcomes

  1. Score on the Perceived Stress Scale (PSS)

    The Perceived Stress Scale (PSS) is a 10-item scale that was developed to measure the degree to which situations in one's life are appraised as stressful. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. Scores range from 0 to 40 with higher scores indicating a worse outcome.

    Time frame: Week 1

  2. Score on the Perceived Stress Scale (PSS)

    The Perceived Stress Scale (PSS) is a 10-item scale that was developed to measure the degree to which situations in one's life are appraised as stressful. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. Scores range from 0 to 40 with higher scores indicating a worse outcome.

    Time frame: Week 5

  3. Score on the Perceived Stress Scale (PSS)

    The Perceived Stress Scale (PSS) is a 10-item scale that was developed to measure the degree to which situations in one's life are appraised as stressful. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. Scores range from 0 to 40 with higher scores indicating a worse outcome.

    Time frame: Week 10

  4. Mean Gestational Age

    Number of completed weeks/days of pregnancy will be collected and the mean will be calculated.

    Time frame: Up to 43 weeks

07

Study locations

1 of 2 sites recruiting
  • Louis Armstrong Center for Music and Medicine at Mount Sinai Health System
    New York, New York 10003, United States
    Active, not recruiting

    Not enrolling at this site.

  • Columbia University Irving Medical Center/NewYork Presbyterian
    New York, New York 10032, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared, but de-identified composite data with be shared with authorized recipients at the end of the study.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Oct 2027, 13 months after the start.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 13 months is below that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Jul 2027 → Oct 2027 and completion Aug 2027 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 6, 2023
First posted
Jul 14, 2023
StartActual
Sep 29, 2026
Primary completionEst.
Oct 31, 2027was Jul 2027
CompletionEst.
Oct 31, 2027was Aug 2027
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 5, 2026
Sites
2 sites changed recruiting status (1 now active, not recruiting, 1 now recruiting)
Show 2 sites
  • Louis Armstrong Center for Music and Medicine at Mount Sinai Health System · New York, United Statesno status→Active, not recruiting
  • Columbia University Irving Medical Center/NewYork Presbyterian · New York, United Statesno status→Recruiting
Oct 5, 2026
Start date
Sep 15, 2026→Sep 29, 2026 (actual)
Oct 5, 2026
Primary completion
Jul 30, 2027→Oct 31, 2027
Oct 19, 2026
Study completion
Aug 29, 2027→Oct 31, 2027
Oct 19, 2026
Show all 2 updates
  1. Oct 19, 2026
    Primary completion Jul 30, 2027→Oct 31, 2027
    Study completion Aug 29, 2027→Oct 31, 2027
    + 1 other change: verification date
  2. Oct 5, 2026
    Not yet recruiting→Recruiting
    2 sites changed recruiting status (1 now active, not recruiting, 1 now recruiting)
    Show 2 sites
    • Louis Armstrong Center for Music and Medicine at Mount Sinai Health System · New York, United Statesno status→Active, not recruiting
    • Columbia University Irving Medical Center/NewYork Presbyterian · New York, United Statesno status→Recruiting
    Start date Sep 15, 2026→Sep 29, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05945264
Responsible party
Jacquelyn Taylor (Helen F. Pettit Professor of Nursing; Executive Director of Columbia Nursing's Center for Research of People of Color, Columbia University) — Principal investigator
First posted
Jul 14, 2023
Start date
Sep 29, 2026
Primary completion
Oct 31, 2027 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Jacquelyn Taylor, PhD
Contact
jyt2116@cumc.columbia.edu
347-978-2871
Joanne V. Loewy, DA, LCAT, MT-BC
Contact
joanne.loewy@mountsinai.org
212-420-3484
Jacquelyn Taylor, PhD
principal investigator · Columbia University
Joanne V. Loewy, DA, LCAT, MT-BC
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion